Updates are available Correction dated 2020-08-20
Click to view Correction: https://doi.org/10.1038/s41467-020-18044-0
-
Authors
Scharenberg, Samantha G. https://orcid.org/0000-0002-3730-1662
Poletto, Edina https://orcid.org/0000-0003-0554-0295
Lucot, Katherine L. https://orcid.org/0000-0001-5481-6206
Colella, Pasqualina https://orcid.org/0000-0002-4268-2391
Sheikali, Adam
Montine, Thomas J.
Porteus, Matthew H. https://orcid.org/0000-0002-3850-4648
Gomez-Ospina, Natalia https://orcid.org/0000-0002-6740-1154
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (5K08NS102398-02)
- License Information
-
More Information
Article History
Received: 30 August 2019
Accepted: 10 June 2020
First Online: 3 July 2020
Change Date: 20 August 2020
Change Type: Correction
Change Details: An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Competing interests
: M.H.P. declares that he is a consultant and has equity interest in CRISPR Tx and Allogene Tx, and he states that neither company has had input or opinions on the subject matter described in this manuscript. The other authors declare no competing interests.
